Dr Reddy’s

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Dr Reddy’s to distribute Sanofi’s paediatric and adult vaccine brands in India

The partnership with Sanofi gives Dr. Reddy’s a strong portfolio and major presence in the vaccine segment taking it to…

March 27, 2024 17:59 IST

The revenue of the Hyderabad-based company rose by 14% year-on-year to Rs 76,727 million, according to a BSE filing.

Dr Reddy’s may join race to acquire Novartis’ India arm

The exclusive sales and distribution agreement includes medicines such as the Voveran range, calcium range and Methergine.

February 18, 2024 06:30 IST

Dr Reddy’s Laboratories, Q2FY24 results, pharmaceutical, revenue, profit, EBITDA, capital expenditure, R&D investments, cash flow, Generics business, new products, Pharmaceutical Services and Active ingredients, price erosion

Dr Reddy’s Q2 Results: Profit rises 30% to Rs 1482.20 crore, beats estimates

Dr Reddy’s Laboratories posted revenue from operations at Rs 6902.60 crore, up 9 per cent as against Rs 6331.80 crore…

October 27, 2023 17:16 IST

dr reddys, dr reddys rating, dr reddys growth

Rating: Reduce – Dr Reddy’s to focus on innovation

Growth to be driven by over the counter drugs and specialty products

June 27, 2023 02:30 IST

USFDA closes inspection at Dr Reddy’s API plant

The inspection was conducted from June 12 to 16, 2023, and closed with zero observations.

June 18, 2023 04:30 IST

India’s Dr Reddy’s Labs posts 11-fold jump in Q4 profit

Dr Reddy’s consolidated revenue jumped 15.8% to 62.97 billion rupees, while total operating expenses fell 13.3%.

May 10, 2023 19:20 IST

Dr Reddys, Dr Reddys lab, Dr Reddys news, Dr Reddys founder, Dr Kallam Anji Reddy

Dr Reddy’s to fulfil founder’s ‘unfinished agenda’ on new drug discovery

Ten years since his passing, the company, led by his family, organised the first Dr Anji Reddy Memorial Lecture on…

Updated: March 15, 2023 18:54 IST

Rating: buy; Dr Reddy’s and Mayne deal is a valuable investment

Despite competitive generics mkt, purchase is a good investment.

March 6, 2023 04:10 IST

Dr Reddy’s Q2 net profit beats estimates, up 12%

The company’s revenue went up 9% to Rs 6,306 crore as against Rs 5,763 crore while it reported an Ebitda…

October 29, 2022 03:30 IST

Generic Revlimid pays off: Dr Reddy’s PAT up 12 pc at Rs 1,113 cr in Q2

The company launched generic Revlimid (Lenalidomide) capsules in the US market during the quarter.

October 28, 2022 18:53 IST

Dr. Reddys, Dr Reddys laboratories, Bortezomib, health news, pharma news,

Dr. Reddy’s Laboratories launches Bortezomib for Injection in US

Meanwhile, Dr. Reddy’s Bortezomib for Injection is supplied in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous…

Updated: July 27, 2022 21:15 IST

Dr Reddys, Dr Reddy labs, health news, pharma news,

Dr Reddy’s sets its goal to triple its reach to 1.5 billion patients by 2030

The company also said it will have three innovative products improving the standard of treatment every year. On carbon emissions,…

July 7, 2022 20:24 IST

Dr Reddy’s settles patent litigation with Indivior, Aquestive Therapeutics

On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to…

June 30, 2022 12:01 IST

Dr Reddy's, Sorafenib tablets, health news, pharma news,

Dr Reddy’s share price soars 9.5% in 5 days, brokerages expect another 15% jump; check target price

Dr Reddy’s share price has jumped 9.5% in the last five days. The stock has rallied after the company last…

May 23, 2022 10:44 IST

Dr Reddy’s shares may rally 27% on double-digit growth; Sharekhan says buy, check target price

Dr Reddy’s Q4FY2022 performance is expected to be weak, given the elevated cost pressures leading to expected margin contraction. Adverse…

April 15, 2022 15:09 IST

Binnopharm to acquire 2 anti-bacterial brands from Dr Reddy’s

The Binnopharm Group, which is one of the leading pharmaceutical production companies in Russia, has inked a deal with Dr…

Updated: February 21, 2022 12:24 IST

Its consolidated revenue during July-September 2021 stood at Rs 5,763.2 crore. It was Rs 4,896.7 crore in the year-ago period, it added.

Dr Reddy’s Q4 profit dips 29 pc to Rs 557 cr

Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in…

May 14, 2021 14:57 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Big Aadhaar update from November 2025: No document upload needed — UIDAI to verify details automatically

F-1 visa denied for applicant after single question at US Consulate

India agrees to cut Russian oil imports, US may slash tariffs to 15% under new trade deal: Report

India agrees to cut Russian oil purchase, open agriculture- Trump may reduce tariff to 15%: Report

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

Credit cover scheme for MSMEs to be compact, likely by Q4

India News1 hr ago

The government will launch a credit guarantee scheme for MSMEs in the next quarter to assist them in dealing with US tariffs and other challenges. The scheme will cover 100% of loans given by lenders, excluding deliberate defaulters. The ECLGS has been successful in improving asset quality and reducing loan defaults. The formalization of MSMEs has also aided banks in accessing reliable data.

View all shorts